Document Type : Research Paper

Authors

1 Department of Biology, College of Education for Pure Science, Mosul University, Mosul, Iraq

2 Department of Pathology and Poultry Diseases, College of Veterinary Medicine, University of Mosul, Mosul, Iraq

Abstract

The current study intends to look at the impact of the fluoxetine hydrochloride on specific tissues lung and pancreas of mature pregnant mice. The two doses used during the study were 45,75mg/kg b.w. from the 7th to the 17th day of pregnancy. Experimental animals received fluoxetine orally at a dosage of 45mg/kg b.w. The findings indicate variable pathologic changes in the lungs. At the dose of 75 mg/kg b.w. hyperplasia of pneumocytes occurred. In the pancreas, there were no detectible lesions at the dose of 45mg/kg b.w. while at the dose of 75 mg/kg b.w. the severity of tissue lesions was seen. In conclusion, antidepressants may stimulate oxidative injury throughout the body's internal organs, particularly if taken at high doses during pregnancy. Consequently, these lesions have a great impact on the heath of both fetus and pregnant mice since the most common lesions were observed in fetus which cause abortion which effect on the health of pregnant mice.

Highlights

Consequently, these lesions have a great impact on the heath of both fetus and pregnant mice since the most common lesions were observed in fetuses which causes abortion which affects the health of pregnant mice.

Keywords

Main Subjects

Toxicity of fluoxetine hydrochloride on some selected vital organs of pregnant mice Mus musculus

 

Baidaa Abdul-Aziz Mohammed1 and Saevan Saad Al-Mahmood2

 

1Department of Biology, College of Education for Pure Science, 2Department of Pathology and Poultry Diseases, College of Veterinary Medicine, University of Mosul, Mosul, Iraq

 

baidaamohammed@uomosul.edu.iq,

saevan981@yahoo.com, 0000-0002-9693-0354

 

Abstract

 

The current study intends to look at the impact of the fluoxetine hydrochloride on specific tissues lung and pancreas of mature pregnant mice. The two doses used during the study were 45,75mg/kg b.w. from the 7th to the 17th day of pregnancy. Experimental animals received fluoxetine orally at a dosage of 45mg/kg b.w. The findings indicate variable pathologic changes in the lungs. At the dose of 75 mg/kg b.w. hyperplasia of pneumocytes occurred. In the pancreas, there were no detectible lesions at the dose of 45mg/kg b.w. while at the dose of 75 mg/kg b.w. the severity of tissue lesions was seen. In conclusion, antidepressants may stimulate oxidative injury throughout the body's internal organs, particularly if taken at high doses during pregnancy. Consequently, these lesions have a great impact on the heath of both fetus and pregnant mice since the most common lesions were observed in fetus which cause abortion which effect on the health of pregnant mice.

 

Keywords: Fluoxetine, Mice, Histopathology, Pregnancy, Lung

 

سمیة الفلوکستین هایدروکلورید على بعض الأعضاء الحیویة المختارة فی الفئران الحوامل Mus musculus

 

بیداء عبدالعزیز محمد و سیڤان سعد المحمود

 

فرع علم الأحیاء، کلیة التربیة للعلوم الصرفة، 2فرع الأمراض وأمراض الدواجن، کلیة الطب البیطری، جامعة الموصل، الموصل، العراق

 

الخلاصة

 

أخذت الدراسة الحالیة على عاتقها التحری عن تأثیر عقار فلوکستین هایدروکلوراید على کل من الرئة والبنکریاس فی الفئران البالغة الحوامل. استخدمت فی الدراسة الحالیة جرعتین هما: 45، 75 ملغم /کغم من وزن الجسم. وجرعت الفئران الحوامل فمویا بالعقار من الیوم 7 إلى یوم 17 من الحمل. أظهرت النتائج تغیرات نسجیة مرضیة مختلفة فی الرئة عند الجرعة 45 ملغم /کغم من وزن. ازدادت حدة الآفات النسجیة المرضیة عند الجرعة 75 ملغم /کغم من وزن الجسم، فضلا عن ظهور فرط التنسج فی الخلایا الرئویة. لم تظهر أفات نسجیة مرضیة واضحة عند الجرعة 45 ملغم /کغم من وزن الجسم فی البنکریاس، فی حین عند الجرعة 75 ملغم /کغم من وزن الجسم لوحظ احتقان الوعاء الدموی وتفجی سایتوبلازم الخلایا البنکریاسیة وتضخم بعضها فضلا عن زیادة الضرر النسجی عند الجرعة 75 ملغم /کغم. نستنتج من ذلک أن استخدام مضادات الاکتئاب قد یسبب زیادة الضغط التأکسدی النسجی فی الأعضاء الداخلیة للجسم خاصة إذا تم استخدامه خلال فترة الحمل بجرع عالیة، وبالنتیجة فان هذه الآفات لها تأثیر کبیر على صحة کل من الأجنة وأمهات الفئران الحوامل وبما أن اغلب الآفات المرضیة التی تم تسجیها کانت فی الأجنة والتی تسبب الإجهاض وبالتالی تؤثر على صحة أمهات الفئران الحوامل.

 

Introduction

 

Recently, the abuse of antidepressants such as fluoxetine is a significant problem worldwide (1). Those drugs are often used in depression treatment. They may help depressed people to recover from their sickness, especially pregnant women who suffer from depression and emotional changes during pregnancy and after childbirth (2). One of the newest antidepressant drugs is Fluoxetine Hydrochloride (3). The drug's chemical formula is C17 H18 F3NO, and the scientific name of the drug is N-methyle-3-phenyle1-1-3 (4-trifluoromethyl) phenoxylpropan-1-amine (4). Fluoxetine metabolism is done in the liver, and the drug is metabolized into norfluoxetine. Norfluoxtine is the drug's active metabolite, which has been directly linked to medical and toxicological effects. It is the active metabolite of the drug directly linked to medical and toxicological effects (5). About 80% of the drug is excreted with urine, and 57% is excreted with feces (6). Moreover, the drug has a maternal effect. The severity of the effect depends on the dose and duration of exposure (7). Medical reports showed that the drug causes pulmonary hypertension syndrome in babies (8). Fluoxetine administration throughout gestation may indeed cause a slow formation of the lungs (9). The drug caused an increase in mortality and altering the structure of phospholipids, hepatic changes when given to rats at a dosage of 10,50 mg/kg b.w. (10). The drug induces oxidative stress, which causes testicular damage, a significant decrease in the weight of reproductive organs, and affects the level of testosterone in the mice (11). Drug administration also causes injuries in the vital organs of the body (12). Several studies referred to the drug's effect on carbohydrate metabolism and the function of beta cells (13).

The objective of this research project was to assess the impact of fluoxetine administration on the concentrations of 45,75 mg /kg of b.w. along with the maternal lung and pancreas of pregnant mice Mus musculus to evaluate the harmful effect of the drug on them.

 

Materials and methods

 

In our investigation, twenty-one pregnant mice, aged three months, weighted 29 ± 3 gm, were used. Animals were taken from the College of Veterinary Medicine's animal house, Mosul University, Mosul, Iraq, and housed in the animals' house of the Biology Department, College of Education for Pure Science. Animals were caged in plastic cages, supported with free access to food and water, fed with a standard diet, the room temperature was 25ºC, the animals were exposed to a regular light-dark cycle (14). The drug used in the study is fluoxetine 20 mg capsules produced by Bristol Laboratories Ltd., Bristol house, Unite 3, Canalside, Northbridge Road, United Kingdom. For the mating process, two females for one male were placed together in the same cage overnight. The next morning females with vaginal plugs were isolated in separate cages and kept together until the 7th day of pregnancy. Animals’ housing was done following the standard guidelines for the use and care of experimental animals.

The pregnant mice (n=21) were divided into three groups (each group consisted of 7 pregnant mice). Group I (control group): The pregnant mice (n=7) were administered with 0.2ml of distilled water orally from the day 7th until the 17th of pregnancy. Group II: The pregnant mice (n=7) were administered orally with 45mg/kg b.w. of fluoxetine drug from the 7th day until the 17th day of pregnancy. Group III: in this group, the pregnant mice (n=7) were administered 75 mg/kg b.w. of fluoxetine drug from day 7th until day 17th of pregnancy.

 

Doses preparation

The drug solution was prepared by dissolving each concentration in 5 ml of distilled water (stock solution). The doses rates were between o.13 - 0.15 ml depending on pregnant mice weight. Those doses had been chosen depending on the LD50 of the drug, which is 100 mg/kg b.w. (15). The doses (drug solution) were prepared freshly every day during the experiments period.

 

Histopathological preparation

On the day 17th of pregnancy, all pregnant mice were sacrificed and dissected, maternal lung and pancreas were dissected. Specimens were fixed in formalin 10% for 48 hours; later, they were washed with distilled water for two hours and processed with routine paraffin embedding technique (16). Sections were stained with hematoxylin and eosin (17).

 

Results

 

Histopathological observations of the lung of adult pregnant mice

Light microscope examination of the control lung section of the pregnant mice Mus musculus showed normal appearance of lung histology (Figure 1). Lung sections collected from pregnant mice performed 45 mg/kg b.w. of fluoxetine from the 7th until the 17th day of pregnancy showed satisfactory Histopathological lesions represented with serofibrinous edema in the air space of alveoli and infiltration of inflammatory cells as well as enlarged airspace and mild thickening of alveolar septa (Figure 2) as well as degeneration of the pulmonary lining epithelium cells and congestion (Figure 3). While the examination of the lung sections obtained from pregnant mice given 75 mg/kg b.w. of fluoxetine drug orally for the same period above showed that previous lesions were increased, especially the congestion of blood vessel (Figure 4) as well as hyperplasia of the lung epithelium tissue was observed (Figure 5).

 

 

 

Figure 1: A cross-section photomicrograph of the lung of the control pregnant mouse Mus musculus showing normal lung histology. (10x. H&E).

 

 

 

Figure 2: A cross-section photomicrograph of the lung of pregnant mouse Mus musculus treated with fluoxetine drug at the dose of 45 mg/kg of b.w. from the 7th day until 17th day of pregnancy showing serofibrinous edema (1), enlargement of pulmonary air space (black arrow), mild thickening of alveolar septa (2), infiltration of inflammatory cells (3). (400x. H&E).

 

 

 

Figure 3: A cross-section photomicrograph of the lung of the pregnant mouse Mus musculus treated with fluoxetine drug at the dose of 45 mg/kg of b.w. from the 7th day until the 17th day of pregnancy showing degeneration of lung epithelium cells (4) and congestion (5). (10x. H&E).

 

 

 

Figure 4: A cross-section photomicrograph of the lung of the pregnant mouse Mus musculus treated with fluoxetine drug at the dose of 75 mg/kg of b.w. from day 7 to day 17 during pregnancy shows an increase in the congestion of blood vessels (7). (10x. H&E).

 

 

 

Figure 5. A cross-section photomicrograph of the lung of the pregnant mouse Mus musculus treated with fluoxetine drug at the dose of 75 mg/kg of b.w from day 7 to day 17 during pregnancy. showing hyperplasia of tracheal epithelium cells (black arrows). (10x. H&E).

 

Histopathological observations of the pancreas of pregnant mice

Light microscope examination of the control pancreas of pregnant mice Mus musculus showed normal lobules and normal pancreatic cells (Figure 6). Pancreas sections were obtained from pregnant mice given 45mg/kg b.w. of fluoxetine drug orally from the 7th until the 17th day of pregnancy. The histological changes and the dose increase were increased, so sections of the pancreas obtained from the pregnant mice given 75mg/kg b.w. of fluoxetine drug orally for the same period above revealed vacuolation of the pancreatic cells (Figure 7). Hypertrophy of some of them, congestion of the blood vessel, and the increase of eosinophilia of some pancreatic cells cytoplasm (Figure 8).

 

 

 

Figure 6: Cross-section photomicrograph of the pregnant mouse Mus musculus's control pancreas shows normal pancreatic lobules and normal pancreatic cells. (10x. H&E).

 

 

 

Figure 7: Cross-section photomicrograph of the pancreas of pregnant mice Mus musculus treated with fluoxetine drug at the dose of 75 mg/kg of b.w. from day 7 to day 17 during pregnancy showing vacuolation of pancreatic cells (black arrows). (10x. H&E).

 

 

 

Figure 8: Cross-section photomicrograph of the pancreas of pregnant mouse Mus musculus that treated with fluoxetine drug at the dose of 75 mg/kg of b.w. from day 7 to day 17 during pregnancy showing hypertrophy of some pancreatic cells (thin black arrow), eosinophils of some pancreatic cells cytoplasm (black arrows heads), congestion of the blood vessel (thick black arrow). (400x. H&E).

 

Discussion

 

In our study, the Macroscopical examination of the lung of pregnant mice administrated orally with 45,75 mg/kg b.w. of fluoxetine showed serofibrinous edema in the alveolar air space, degeneration of the alveolar lining epithelium, infiltration of inflammatory cells, congestion, and hyperplasia. The lesions were increased as well, as the dose increased. Those lesions were similar to those reported by (9,12,18). This study's findings correspond with those of (19) as all of them confirmed that taking fluoxetine during pregnancy causes hyperplasia of alveolar septa. The findings of this study may be directly attributable to that inflammatory response caused by fluoxetine. This induction may be linked to fluoxetine impairing the phospholipids metabolism, which involves some pathological lesions such as inflammatory cells infiltration and degeneration (20). on the other hand, it may be due to the use of fluoxetine during pregnancy, which may alter some metabolic pathways and increase in the levels of oxidative stress which in turn cause formation of destructive free radical, those molecules disturb and destroy the functions and structure of the lung cells (21).

The findings from the current study had shown histopathological lesions in pregnant mice's pancreas that were treated with fluoxetine at 45, 75 mg/kg b.w. for the preceding period, so the most noticeable lesions at the 75 mg/kg dose were blood vessel congestion, vacuolation of pancreatic cytoplasm and hypertrophy of some pancreatic cells. Study findings did not correspond with the findings of (22). At the same time, the present study results were similar to the finding of (23). The results were somewhat similar to the finding of (24). The finding of the current study may be due to the, that using fluoxetine for depression treatment during pregnancy may involve inducing cytotoxic mechanism in the body cells, which in turn increase the production of free radical oxygen species that destroy cellular mitochondria, proteins, lipids, and nucleic acids (25).

 

Conclusion

 

In conclusion, antidepressants may stimulate oxidative injury throughout the body's internal organs, particularly if taken at high doses during pregnancy. Consequently, they should always be used caution to avoid adversely.

 

Acknowledgements

 

Authors would express the thanks to University of Mosul, to support current study.

 

Conflict of interest

 

No conflict of interest.

  1. Hubbard JR, Martin PR. Substance abuse in the mentally and physically disabled. New York: CRC Press; 2001. 26 p.
  2. Fleschler R, Peskin MF. Selective serotonin reuptake inhibitors (SSRIs) in Pregnancy: A review. MCN Am J Matern Child Nurs. 2008;33:355-361. DOI: 10.1007/s40263-016-0338-3
  3. Atamura AC, Moro AR, Perudanni M. Clinical pharmacokinetics of fluoxetine. Clin Pharm. 1994;26(3):201-214. DOI: 10.2165/00003088-199426030-00004
  4. Myers RL. The most important chemical compounds: A reference guide. 1st ed. Westport: Greenwood Press; 2007. 128 p.
  5. Ozden H, Bildirici KI, Ustüner D, Ustüner C, Cengiz BP, Tulay A, Yılmaz V. Histopathologic examination of rat liver after experimental application of fluoxetine. Türkiye Ekopatoloji Dergisi. 2005;11 9-15. [available at]
  6. Wiliams K, Brignell A, Randall M, Silone N, Hazell P. Selective serotonin reuptake inhibitors (SSIRs) for autism spectrum disorders (ASD). Sys Rev. 2013;8(8):46-77. DOI: 10.1002/14651858.CD004677.pub3
  7. Berard A. Antidepressant use during pregnancy and the risk of major congestion malformations in a cohort of depressed pregnant women: An updated analysis of the Quebec Pregnancy Cohort. BMJ. 2017;7:13-21. DOI: 10.1136/bmjopen-2016-013372
  8. Fornaro E, Li D, Pan J, Belik J. Prenatal exposure to fluoxetine induces fetal pulmonary hypertension in the rat. Am J Res Crit Care Med. 2007;76:1035-1040. DOI: 10.1164/rccm.200701-163OC
  9. Ghavamabadi RT, Taghipour Z, Hassanipour M, Shariati M. Effect of maternal fluoxetine exposure on lung heart and kidney development in rat neonates. Iran Basic Med Sci. 2018;21(4):417-421. DOI: 10.22038/IJBMS.2018.27203.6650
  10. Bendele RA, Adams ER, Hoffman WP, Gries CL, Morton DM. Carcinogenicity studies of fluoxetine hydrochloride in rats and mice. Vet Rec. 1992;34(4):23-29. [available at]
  11. Hajizadeh Z, Mehranjani M.S, Najafi G, Shariatzadeh SA, Jalali AS. Black grape seed extract modulates fluoxetine-induced oxidative stress and cytotoxicity in the mouse testis. Jundishapur J Nat Pharm Prod. 2016;11(2):27-32. DOI: 10.17795/jjnpp-27512
  12. Rosenberg T, Lattimer R, Montgomery P, Wiens C, Levy L. The relationship of SSRI and SNRI usage with interstitial lung disease and bronchiectasis in an elderly population: a case-control study. Clin Interv Aging. 2017;12:19-20. DOI: 10.2147/CIA.S144263
  13. De Long NE, Hyslop JR, Raha S, Hardy DB, Holloway AC. Fluoxetine-induced pancreatic beta-cell dysfunction: New insight into the benefits of folic acid in the treatment of depression. J Affect Dis. 2014;12:90-101. DOI: 10.1016/j.jad.2014.04.063
  14. Czeizel AE, Puho EH, Acs N, Banhidy F. Use of specified critical periods of different congenital abnormalities instead of the first-trimester concept. Res Clin Mol Teratol. 2008;82(3):139-146. DOI: 10.1002/bdra.20431
  15. Suchard JR. Fluoxetine over dose-induced seizure. West J Med. 2008;9(3):154-156. [available at]
  16. A-Hajj HA. Optical laboratory preparation. 1st ed. Jordan: Dar Al-Massera Press; 2010. 34-69 p.
  17. Suvarna S. K, Layton C, Bancroft JD. Theory and practice of histological techniques. 7th ed. London: Churchill Livingstone press; 2013. 173-187 p.
  18. Gonzalez RJ, Zande DS, Ros PR. Fluoxetine hydrochloride (Prozac)-induced pulmonary disease. Chest. 1995;107(6):1763-5. DOI: 10.1378/chest.107.6.1763  
  19. Dauger S, Ferkdadji L, Saumon G, Vardon G, Peuchmaur M, Gaultier C, Gallego J. Neonatal exposure to 65% oxygen durably impairs lung architecture and breathing pattern in adult mice. Chest. 2003;123(3):530-538. DOI: 10.1378/chest.123.2.530
  20. Davis EA, Oohony MS. Adverse drug reaction in special population the elderly: ADRs in the elderly. British J Clin Pharmacol. 2015;1(2):101-110. DOI: 10.1111/bcp.12596
  21. Allen JN. Drug-induced eosinophilic lung disease. Clin Chest Med. 2004;25(1):77-88. DOI: 10.1016/S0272-5231(03)00141-2
  22. Mekahli D, Bultynck G, Parys JB, De Smedt H, Missiaen L. Endoplasmic-reticulum calcium depletion and disease. Perspect Biol. 2011;3:17. DOI: 10.1101/cshperspect.a004317
  23. Chang HY, Chen SL, Shen MR, Kung ML, Chuang LM, Chen YW. Selective serotonin reuptake inhibitor fluoxetine impairs E-cadherin-mediated cell adhesion and alters calcium homeostasis in pancreatic beta cells. Sci Report. 2017;(1):3515. DOI: 10.1038/s41598-017-03747-0
  24. Youssef S. Effect of fluoxetine on the pancreas of adult male Albino rats and the possible protective role of omega-3: light and possible electron microscope study. Inter Develop Anat. 2017;(3):45-56. [available at]
  25. Steinberg WM, Nauck MA, Zinman B, Daniels GH, Bergenstal RM, Mann JF. Leader 3-lipase and amylase activity in subjects with type 2 diabetes: baseline data from over 9000 subjects in the leader trial. Pancreas. 2014;43:1223-1231.  DOI: 10.1097/MPA.0000000000000229